BioCentury
ARTICLE | Company News

CareX, 7TM deal

May 29, 2006 7:00 AM UTC

7TM acquired CareX for an undisclosed amount of stock. The deal adds CareX’s cannabinoid CB1 receptor antagonists, which are in lead optimization, to 7TM’s obesity pipeline. The Danish company’s TM3...